Bodo Levkau

12.7k total citations · 2 hit papers
157 papers, 9.2k citations indexed

About

Bodo Levkau is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Bodo Levkau has authored 157 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 41 papers in Cardiology and Cardiovascular Medicine and 34 papers in Surgery. Recurrent topics in Bodo Levkau's work include Sphingolipid Metabolism and Signaling (48 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Lipid Membrane Structure and Behavior (14 papers). Bodo Levkau is often cited by papers focused on Sphingolipid Metabolism and Signaling (48 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Lipid Membrane Structure and Behavior (14 papers). Bodo Levkau collaborates with scholars based in Germany, United States and Japan. Bodo Levkau's co-authors include Elaine W. Raines, Russell Ross, Petra Keul, Gerd Assmann, Michael Schäfers, Gerd Heusch, Manfred Fobker, Jerzy–Roch Nofer, Barbara Herren and Karin von Wnuck Lipinski and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Bodo Levkau

155 papers receiving 9.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3

2004 538 citations Jerzy‐Roch Nofer, Karin von Wnuck Lipinski et al. profile →
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3

2004 510 citations Karin von Wnuck Lipinski, Hideo A. Baba et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bodo Levkau	4.8k	2.0k	1.8k	1.5k	1.2k	157	9.2k
Chieko Mineo	3.6k 0.7×	1.7k 0.9×	871 0.5×	1.6k 1.1×	900 0.7×	106	7.7k
Yi Zhu	3.4k 0.7×	1.2k 0.6×	885 0.5×	1.2k 0.8×	1.1k 0.9×	154	7.6k
Jean‐Marc Herbert	3.6k 0.8×	2.0k 1.0×	3.5k 1.9×	838 0.6×	1.1k 0.9×	165	10.7k
Karin Bornfeldt	5.2k 1.1×	1.8k 0.9×	1.7k 1.0×	718 0.5×	1.3k 1.0×	151	11.1k
Loren G. Fong	6.6k 1.4×	1.6k 0.8×	2.8k 1.6×	2.1k 1.5×	1.1k 0.9×	181	12.1k
Ichiro Shiojima	7.3k 1.5×	2.2k 1.1×	4.4k 2.4×	779 0.5×	1.1k 0.9×	169	12.1k
Stuart J. Shankland	6.8k 1.4×	1.5k 0.8×	875 0.5×	667 0.5×	752 0.6×	229	15.2k
Fuad N. Ziyadeh	6.3k 1.3×	1.6k 0.8×	2.1k 1.2×	651 0.4×	724 0.6×	161	15.7k
Nanping Wang	3.9k 0.8×	1.1k 0.5×	817 0.5×	768 0.5×	1.2k 1.0×	167	7.7k
Hans‐Peter Hammes	4.6k 1.0×	901 0.5×	784 0.4×	869 0.6×	855 0.7×	179	11.7k

Countries citing papers authored by Bodo Levkau

Since Specialization

Citations

This map shows the geographic impact of Bodo Levkau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodo Levkau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodo Levkau more than expected).

Fields of papers citing papers by Bodo Levkau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodo Levkau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodo Levkau. The network helps show where Bodo Levkau may publish in the future.

Co-authorship network of co-authors of Bodo Levkau

This figure shows the co-authorship network connecting the top 25 collaborators of Bodo Levkau. A scholar is included among the top collaborators of Bodo Levkau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bodo Levkau. Bodo Levkau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poschmann, Gereon, Martin Busch, Zhaoping Ding, et al.. (2025). A secretome atlas of cardiac fibroblasts from healthy and infarcted mouse hearts. Communications Biology. 8(1). 675–675. 1 indexed citations

Klingenberg, Roland, Andreas Leiherer, Dobromir Dobrev, et al.. (2025). Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets. Cardiovascular Research. 121(9). 1345–1358. 2 indexed citations

Mehmeti, Ilir, et al.. (2024). The fate of intracellular S1P regulates lipid droplet turnover and lipotoxicity in pancreatic beta-cells. Journal of Lipid Research. 65(8). 100587–100587. 4 indexed citations

Müller, Melanie, Margaretha A. Skowron, Patrick Petzsch, et al.. (2024). Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies. Experimental Cell Research. 439(1). 114055–114055. 1 indexed citations

Behnke, Kristina, Philip Kirschner, Sonja Hartwig, et al.. (2024). Identification of myeloid-derived growth factor as a mechanically-induced, growth-promoting angiocrine signal for human hepatocytes. Nature Communications. 15(1). 1076–1076. 7 indexed citations

Wagner, Stefan, Petra Keul, Sven Hermann, et al.. (2024). Synthesis, radiosynthesis and biochemical evaluation of fluorinated analogues of sphingosine-1-phosphate receptor 3 specific antagonists using PET. Bioorganic & Medicinal Chemistry. 104. 117697–117697. 1 indexed citations

Bönner, Florian, Christian Jung, Amin Polzin, et al.. (2023). SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction. BMC Cardiovascular Disorders. 23(1). 232–232. 2 indexed citations

Ghaderi, Shahrooz, Karin von Wnuck Lipinski, Markus H. Gräler, et al.. (2023). Sphingosine-1-phosphate suppresses GLUT activity through PP2A and counteracts hyperglycemia in diabetic red blood cells. Nature Communications. 14(1). 8329–8329. 9 indexed citations

Wagner, Johannes Maximilian, Sarah Weske, Sebastian Lotzien, et al.. (2023). Pharmacological elevation of sphingosine‐1‐phosphate by S1P lyase inhibition accelerates bone regeneration after post‐traumatic osteomyelitis. Journal of Cellular and Molecular Medicine. 27(23). 3786–3795. 3 indexed citations

10.

Polzin, Amin, Lisa Dannenberg, Petra Keul, et al.. (2022). S1P Lyase Inhibition Starting After Ischemia/Reperfusion Improves Postischemic Cardiac Remodeling. JACC Basic to Translational Science. 7(5). 498–499. 3 indexed citations

11.

Stuhldreier, Fabian, Thomas Lenz, Marcel Zimmermann, et al.. (2022). The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Cell Death and Disease. 13(11). 938–938. 7 indexed citations

12.

Polzin, Amin, Lisa Dannenberg, Petra Keul, et al.. (2022). Sphingosine-1-Phosphate Improves Outcome of No-Reflow Acute Myocardial Infarction Via Sphingosine-1-Phosphate Receptor 1. ESC Heart Failure. 10(1). 334–341. 8 indexed citations

13.

Gerfer, Stephen, Sören Twarock, Sonja Hartwig, et al.. (2021). Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus. Diabetologia. 64(8). 1834–1849. 33 indexed citations

14.

Schündeln, Michael M., Max Daniel Kauther, Gero Hilken, et al.. (2021). Prednisone prevents particle induced bone loss in the calvaria mouse model. Heliyon. 7(8). e07828–e07828. 2 indexed citations

15.

Dannenberg, Lisa, Martin Pöhl, Philipp Mourikis, et al.. (2019). Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease. Pharmacology. 105(1-2). 118–122. 8 indexed citations

16.

Helten, Carolin, Lisa Dannenberg, Martina Pohl, et al.. (2018). Platelet function testing: dead or alive. Journal of Thrombosis and Haemostasis. 16(5). 984–986. 22 indexed citations

17.

Flögel, Ulrich, Tim Laußmann, Axel Gödecke, et al.. (2005). Lack of Myoglobin Causes a Switch in Cardiac Substrate Selection. Circulation Research. 96(8). e68–75. 54 indexed citations

18.

Schmitz, Klaus J., Florian Grabellus, R. Callies, et al.. (2005). High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Research. 7(2). R194–203. 64 indexed citations

19.

Schmitz, Klaus J., Friedrich Otterbach, R. Callies, et al.. (2003). Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Modern Pathology. 17(1). 15–21. 76 indexed citations

20.

Levkau, Bodo, Kyle J. Garton, Nicola Ferri, et al.. (2001). xIAP Induces Cell-Cycle Arrest and Activates Nuclear Factor-κB. Circulation Research. 88(3). 282–290. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact